+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Vasopressin V2 Receptor (V2R) Antagonist - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025 - Product Thumbnail Image

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Interleukin-33 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin-33 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Opioid Mu Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Mu Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Vascular Endothelial Growth Factor Receptor 3 Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Adenosine Receptor Antagonists - Pipeline Insight, 2025 - Product Thumbnail Image

Adenosine Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025 - Product Thumbnail Image

Non-cystic Fibrosis Bronchiectasis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Cushing Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Cushing Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Complement Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Polycystic Kidney Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Polycystic Kidney Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Clostridioides Difficile Infection (rCDI) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Essential Thrombocythemia (ET) - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Essential Thrombocythemia (ET) - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • February 2025
  • 137 Pages
  • Global
From
Polycythemia Vera - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Polycythemia Vera - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2025
  • 226 Pages
  • Global
From
Kidney Transplant Rejection - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Kidney Transplant Rejection - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2025
  • 176 Pages
  • Global
From
Myelofibrosis (MF) - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Myelofibrosis (MF) - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2025
  • 255 Pages
  • Global
From
Preeclampsia - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Preeclampsia - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • January 2025
  • 124 Pages
  • Global
From
Hypophosphatasia - Epidemiology Forecast-2034 - Product Thumbnail Image

Hypophosphatasia - Epidemiology Forecast-2034

  • Report
  • December 2024
  • 68 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more